Advertisement

Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x100px
Organisation › Details

Forty51 Ventures (Group)

Forty51 is a recently founded Venture Capital firm focused on early stage venture creation in Europe backed by a strong investor syndicate with Stable Asset Management, several Pension funds, family offices and accomplished Biotech entrepreneurs. *

 

Period Start 2022-04-01 established
Products Industry venture capital
  Industry 2 BIOTECH
Person Person Núnez-Garcia, Sara (Forty51 Advisors 202204– Partner + Co-Founder formerly Sofinnova Partners 201410 Associate)
     
  Street 119 Engelgasse
  City 4052 Basel
    Address record changed: 2023-02-13
     
Basic data Employees n. a.
     
    * Document for »About Section«: Mosanna Therapeutics AG. (7/13/22). "Press Release: Mosanna Therapeutics Announces a Seed Financing Round to Advance Development of MOS-118 to Treat Metabolic Obstructive Sleep Apnea". Basel.
     
   
Record changed: 2023-08-30

Advertisement

Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x200px

More documents for Forty51 Ventures (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe 2023 Munich BEU23 650x300px




» top